EVOME MEDICAL TECHNOLOGIES INC. Quarterly Share-based Payment Arrangement, Expense in CAD from Q2 2020 to Q3 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evome Medical Technologies Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2023.
  • Evome Medical Technologies Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was CA$265K, a 30.1% decline year-over-year.
  • Evome Medical Technologies Inc. annual Share-based Payment Arrangement, Expense for 2023 was CA$1.29M.
  • Evome Medical Technologies Inc. annual Share-based Payment Arrangement, Expense for 2021 was CA$1.2M, a 403% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (CAD)
Share-based Payment Arrangement, Expense, Quarterly (CAD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 265K -114K -30.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q1 2023 1.59M 346K -93K -21.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.69M 381K +88.4K +30.2% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 1.6M 379K -67.5K -15.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 1.67M 489K +470K +2462% Mar 1, 2022 May 31, 2022 10-Q 2022-07-15
Q1 2022 1.2M 439K +337K +331% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 860K 292K +223K +323% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 636K 446K +391K +703% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-17
Q2 2021 246K 19.1K +7.88K +70.3% Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
Q1 2021 238K 102K Dec 1, 2020 Feb 28, 2021 10-K 2022-05-31
Q4 2020 69.2K Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-14
Q3 2020 55.6K Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-15
Q2 2020 11.2K Mar 1, 2020 May 31, 2020 10-Q/A 2021-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.